References
- Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88, 5808–5813, 2003.10.1210/jc.2003-030254
- Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93, 1553–1562, 2008.10.1210/jc.2008-0139
- Fierabracci P, Pinchera A, Martinelli S, Scartabelli G, Salvetti G, Giannetti M, Pucci A, Galli G, Ricco I, Querci G, Rago T, Di Salvo C, Anselmino M, Vitti P, Santini F. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg 21, 54–60, 2011.10.1007/s11695-010-0297-6
- Gungunes A, Sahin M, Demirci T, Ucan B, Cakir E, Arslan MS, Unsal IO, Karbek B, Caliskan M, Ozbek M, Cakal E, Delibasi T. Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47, 895–900, 2014.10.1007/s12020-014-0260-8
- Jankovic D, Wolf P, Anderwald CH, Winhofer Y, Promintzer-Schifferl M, Hofer A, Langer F, Prager G, Ludvik B, Gessl A, Luger A, Krebs M. Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg 22, 62–69, 2012.10.1007/s11695-011-0545-4
- Knoops AJ, van der Graaf Y, Mali WP, Geerlings MI. Age-related changes in hypothalamic-pituitary-adrenal axis activity in patients with manifest arterial disease. Endocrine 37, 231–238, 2010.10.1007/s12020-009-9291-y
- Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet 386, 913–927, 2015.10.1016/S0140-6736(14)61375-1
- Lammert A, Nittka S, Otto M, Schneider-Lindner V, Kemmer A, Kramer BK, Birck R, Hammes HP, Benck U. Performance of the 1 mg dexamethasone suppression test in patients with severe obesity. Obesity 24, 850–855, 2016.10.1002/oby.21442
- Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet 367, 1605–1617, 2006.10.1016/S0140-6736(06)68699-6
- Nieman LK. Diagnostic tests for Cushing’s syndrome. Ann NY Acad Sci 970, 112–118, 2002.10.1111/j.1749-6632.2002.tb04417.x12381546
- Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The Diagnosis of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93, 1526–1540, 2008.10.1210/jc.2008-0125238628118334580
- Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27, 193–202, 2004.10.1291/hypres.27.19315080378
- Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M. Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol 67, 225–229, 2007.10.1111/j.1365-2265.2007.02865.x17547690
- Tamada D, Otsuki M, Kashine S, Hirata A, Onodera T, Kitamura T, Shimomure I. Obstructive sleep apnea syndrome causes a pseudo-Cushing’s state in Japanese obese patients with type 2 diabetes mellitus. Endocr J 60, 1289–1294, 2013.10.1507/endocrj.EJ13-0255
- Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P. Screening for Cushing’s syndrome in obese patients. Clinics (Sao Paulo) 65, 9–13, 2010.10.1590/S1807-59322010000100003281528820126340
- van Hulsteijn LT, Pasquali R, Casanueva F, Haluzik M, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol 182, 11–21, 2020.10.1530/EJE-19-066631652416
- Yavuz DG, Apaydin T, Gunhan HG, Uygur MM. Assessment of 1 mg Dexamethasone suppression test in patients with obesity before bariatric surgery. Obesity Surgery 30, 4981–4985, 2020.10.1007/s11695-020-04865-x32803707